Lupin announced that it has received
approval for its Albendazole Tablets USP, 200 mg, from the United States Food and Drug Administration (U.S.
FDA), to market a generic equivalent of Albenza® Tablets, 200 mg, of Impax Laboratories Inc.
Albendazole Tablets USP, 200 mg, are an anthelmintic drug indicated for treatment of:
• Parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm
• Cystic hydatid disease of the liver, lung, and peritoneum, caused by the larval form of the dog tapeworm